Navigation Links
PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
Date:9/21/2009

NES-ZIONA, Israel, Sept. 21 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.

hGH-CTP is being developed to provide growth hormone deficient adults and children with the option to replace the multiple injections per week that are currently required with a once-weekly or bi-monthly injection. The initiation of the trial follows a successful safety and immunogenicity study of hGH-CTP in primates and regulatory approvals by the IRB committee of the Tel-Aviv Medical Center and the Israeli Ministry of Health.

The Phase I trial is a randomized, double-blinded, placebo-controlled, single-dose, dose-escalating study to evaluate the safety, tolerability, and pharmacokinetic and pharmacodynamic properties of hGH-CTP in 24 healthy volunteers. It will be conducted at the Early-Phase Clinical Pharmacology Unit located at the Tel-Aviv Medical Center.

"The initiation of a Phase I clinical trial of our long-acting hGH-CTP represents an important milestone for PROLOR," said Dr. Avri Havron, CEO of PROLOR. "We were delighted with the results of our hGH-CTP studies in primates, which showed that hGH-CTP had an excellent half-life and biological activity and was safe at all doses tested without any signs of immunogenicity. We are now eager to obtain data on its bioactivity in humans."

Dr. Havron continued, "This trial is being conducted at the Early-Phase Clinical Pharmacology Unit at the Tel-Aviv Sourasky Medical Center, a top-notch facility that has a successful track record of conducting more than 250 clinical studies for leading global pharmaceutical and biotech companies in a variety of clinical areas. We look forward to completing the Phase I trial so that we can move ahead with the further clinical develo
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
3. PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
4. PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference
5. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
10. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
11. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... FL (PRWEB) , ... August 04, 2015 , ... ... of rapid point-of-care (POC) diagnostic tests – today announced that Robert A. Gregg, ... Dr. Gregg has more than 30 years of relevant experience and remarkable achievements ...
(Date:8/4/2015)... 4, 2015  Blueprint Medicines (NASDAQ: BPMC ), ... drugs for genomically defined diseases, today announced that ... company overview at the 2015 Wedbush PacGrow Healthcare Conference ... A live webcast of the event will ... Blueprint Medicines website at www.blueprintmedicines.com . An archived ...
(Date:8/4/2015)... ... 2015 , ... On August 4, 2015, the White House will host a ... the United States to talk about their experiences with innovation and present their big ... among the attendees. , One of the day’s aims is to grow the innovation ...
(Date:8/4/2015)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... today announced that it will release its unaudited financial ... after market close on Wednesday, August 12, 2015. The Company ... 2015, at 8:00 a.m. EDT (Thursday, August 13, 2015 ... Company,s financial results and provide an update on recent ...
Breaking Biology Technology:RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2
... I am familiar with bad jobs. , ,My youngest brother ... involved wandering through unfamiliar neighborhoods, worrying about making a daily ... a shared apartment. After a few weeks of this, my ... brother once found a job selling environmentally friendly household products, ...
... the seed capital he needs to fuel his rapidly growing ... are legally allowed to make angel investments. , ,This is ... Wisconsins tech community, Peter M. Skanavis is doing everything he ... angel investments to actually take the plunge and put their ...
... stories coming out of California, but the failure of flight ... one of the weirdest. , ,The radio system used by ... a snit when its regular monthly maintenance wasnt performed and ... but couldnt talk to them, even as the planes converged ...
Cached Biology Technology:Beware the cold-call job interview 2Beware the cold-call job interview 3Beware the cold-call job interview 4Beware the cold-call job interview 5Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 2Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 3Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 4Proactive nightmares 2
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... a reason to be glad about madder: The climbing plant has ... Rice University and the City College of New York have discovered ... of purpurin, an organic dye that can be turned into a ... used since ancient times to create dye for fabrics. ...
... Troy, N.Y. A new study from engineering researchers ... how the little-understood protein osteocalcin plays a significant role ... lead to new strategies and therapeutics for fighting osteoporosis ... by the U.S. National Institutes of Health, the study ...
... Asian soybean rust ( Phakopsora pachyrhizi ) pose a ... because they can be blown great distances by the ... to determine whether these spores are viable. "Finding ... and able to infect plants," said USDA Agricultural Research ...
Cached Biology News:Rice cultivates green batteries from plant 2Rice cultivates green batteries from plant 3Battling brittle bones... with broccoli and spinach? 2Dead or alive? A new test to determine viability of soybean rust spores 2
APG5 autophagy 5-like (S. cerevisiae)...
Human Jagged 2 Biotinylated Affinity Purified PAb...
Mouse/Rat WNK1 Affinity Purified Polyclonal Ab...
Griess Reagent component for determination of nitrite in aqueous solutions....
Biology Products: